Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: correlation with in vivo data and the relationship to intra-enterocyte processes in rats.
about
Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugsOral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulationsA simple quantitative approach for the determination of long and medium chain lipids in bio-relevant matrices by high performance liquid chromatography with refractive index detection.Effect of lipolysis on drug release from self-microemulsifying drug delivery systems (SMEDDS) with different core/shell drug location.Absorption enhancement of adefovir dipivoxil by incorporating MCT and ethyl oleate complex oil phase in emulsion.Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development.Quantification of carbamazepine and its 10,11-epoxide metabolite in rat plasma by UPLC-UV and application to pharmacokinetic study.Advancing In Vitro-In Vivo Extrapolations of Mechanism-Specific Toxicity Data Through Toxicokinetic Modeling.Characterising lipid lipolysis and its implication in lipid-based formulation development.Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.Predictive models for oral drug absorption: from in silico methods to integrated dynamical models.Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs.The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs.Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance.Lipid-based formulations and drug supersaturation: harnessing the unique benefits of the lipid digestion/absorption pathway.Standardization of Nanoparticle Characterization: Methods for Testing Properties, Stability, and Functionality of Edible Nanoparticles.Comparison of lipases for in vitro models of gastric digestion: lipolysis using two infant formulas as model substrates.Encapsulation and Delivery of Crystalline Hydrophobic Nutraceuticals using Nanoemulsions: Factors Affecting Polymethoxyflavone Solubility.Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines.Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.The Effect of Digestion and Drug Load on Halofantrine Absorption from Self-nanoemulsifying Drug Delivery System (SNEDDS).In vivo Evaluation of Self Emulsifying Drug Delivery System for Oral Delivery of Nevirapine.Insights into drug precipitation kinetics during in vitro digestion of a lipid-based drug delivery system using in-line raman spectroscopy and mathematical modeling.In vitro lipolysis and intestinal transport of β-arteether-loaded lipid-based drug delivery systems.Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations.Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems (SNEDDS): the underlying mechanisms for amiodarone and talinolol.Modern prodrug design for targeted oral drug delivery.Recent advances in lipid-based formulation technology.monitoring of the structural change of microemulsions in simulated gastrointestinal conditions by SAXS and FRETA coarse-grained simulation to study the digestion and bioaccessibility of lipophilic nutrients and micronutrients in emulsionIn vitro and in vivo evaluations of the performance of an indirubin derivative, formulated in four different self-emulsifying drug delivery systemsDevelopment of Self-Emulsifying Drug Delivery Systems (SEDDS) for Oral Bioavailability Enhancement of Poorly Soluble DrugsIn vitrolipid digestion models in design of drug delivery systems for enhancing oral bioavailabilityUnravelling the behaviour of curcumin nanoemulsions during in vitro digestion: effect of the surface charge
P2860
Q26774831-FE548F00-BA83-48F6-80C7-4D975BB9B10FQ28534686-CCC41A0D-EA07-43DD-ABA9-C36B3055C384Q30543782-E046C415-ED1F-4DFA-A38D-E40C9FBAE416Q33681221-389F9FD7-DC6B-42D7-A528-81B2B1888615Q33858985-1F56F3F2-7C78-4CFE-B4E1-8E39A3C49860Q34273688-5278C023-9FF8-4862-92FE-DBEB4A40773FQ35064769-61B22BEB-EA5C-4CF6-BE38-69306CC5279FQ36130508-276D4AA6-9EF4-4FD5-BA3D-68DE474CD7D2Q36331543-213B259B-1255-43F9-B055-D7187770F98DQ36748145-3195EB40-89E9-4366-9D93-A760A9FFF147Q36909311-5C0D6635-7DA0-4532-95A6-3354885908BFQ37702234-32B5DDA9-85F2-4CBB-B56A-D9A1124CDF68Q37990748-F0B02EFD-2754-41BD-ADD9-37129265B426Q38115195-A3AEF50C-FA15-4113-9329-39C5955A6B9AQ38119168-D5F5B46D-0D4D-4670-8757-6B8E03B083D5Q38409560-E870251C-02DB-4511-B4B9-54CFD4BFC7F6Q39315998-61462193-A975-4F24-B102-4D6160DBC11DQ40261316-E0C0694A-A22F-4CE3-9B57-46FA8CC0DD40Q41003488-00E1B397-7993-4ED6-B9C3-7838CBC75D4EQ41809141-B871E55F-B6CA-4EDA-B1B5-273751388F72Q42062964-914C3493-D317-47D0-AD1B-26ABD12D2CF1Q42205568-557D8F31-CA0A-4826-A883-578ED9FAD38CQ43852623-6AE1431A-F7A2-40A4-98CE-11A8DA45E90AQ44243385-CCA4386E-614C-4754-9989-E5193C7E310EQ44630513-4B388C88-A875-4B61-8814-0B0961B70597Q44721371-4D369B73-0811-4E9E-9FF0-49C903380170Q51042522-D5AAB0A2-0312-471B-919F-DDFE2B4F9B8EQ54698110-4819AB58-31A8-4878-9115-542A987A7937Q57115469-EB39F3CE-9C9B-4806-AA3C-1D15104EA05FQ57154636-2894E296-AFE9-4709-8629-FDC254C96A84Q58199028-B405C576-95B3-4EEC-8128-5F9D03E4F8B0Q58199061-E9A49B05-161C-44CD-97A3-E11A8F309F5BQ58199115-5B9319CB-2937-4556-8C05-D9AE7BCC1DB8Q58877921-AF96B7E4-CA9A-415F-93CD-B573CF1D851A
P2860
Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: correlation with in vivo data and the relationship to intra-enterocyte processes in rats.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Use of a dynamic in vitro lipo ...... -enterocyte processes in rats.
@ast
Use of a dynamic in vitro lipo ...... -enterocyte processes in rats.
@en
type
label
Use of a dynamic in vitro lipo ...... -enterocyte processes in rats.
@ast
Use of a dynamic in vitro lipo ...... -enterocyte processes in rats.
@en
prefLabel
Use of a dynamic in vitro lipo ...... -enterocyte processes in rats.
@ast
Use of a dynamic in vitro lipo ...... -enterocyte processes in rats.
@en
P1476
Use of a dynamic in vitro lipo ...... -enterocyte processes in rats.
@en
P2093
Amnon Hoffman
Arik Dahan
P304
P356
10.1007/S11095-006-9054-X
P577
2006-08-11T00:00:00Z